Chen, Rong http://orcid.org/0000-0002-7129-4005
Chen, Yuling
Xiong, Ping
Zheleva, Daniella
Blake, David http://orcid.org/0000-0002-8367-3256
Keating, Michael J.
Wierda, William G. http://orcid.org/0000-0002-7357-270X
Plunkett, William http://orcid.org/0000-0001-9311-2164
Funding for this research was provided by:
UT | University of Texas MD Anderson Cancer Center
CLL Global Research Foundation
Cyclacel Pharmaceuticals
Article History
Received: 16 September 2021
Revised: 10 March 2022
Accepted: 18 March 2022
First Online: 5 April 2022
Competing interests
: This study was supported in part by a research funding from Cyclacel Pharmaceuticals to WP and RC. DZ and DB are employed by Cyclacel Pharmaceuticals. The other authors declare no conflicts of interest.